Literature DB >> 15780608

Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents.

C Selvam1, Sanjay M Jachak, Ramasamy Thilagavathi, Asit K Chakraborti.   

Abstract

Curcuminoids were isolated from Curcuma longa and their pyrazole and isoxazole analogues were synthesized and evaluated for antioxidant, COX-1/COX-2 inhibitory and anti-inflammatory activities. The designed analogues significantly enhance COX-2/COX-1 selectivity and possess significant anti-inflammatory activity in carrageenan induced rat paw edema assay. Pyrazole, isoxazole analogues of curcumin (4 and 7) exhibited higher antioxidant activity than trolox. Molecular docking study revealed the binding orientations of curcumin analogues in the active sites of COX and thereby helps to design novel potent inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780608     DOI: 10.1016/j.bmcl.2005.02.039

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  29 in total

1.  Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment.

Authors:  Charlotta D Mock; Brian C Jordan; Chelliah Selvam
Journal:  RSC Adv       Date:  2015-09-02       Impact factor: 3.361

Review 2.  Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry.

Authors:  Subhash Padhye; Deepak Chavan; Shubhangini Pandey; Jyoti Deshpande; K Venkateswara Swamy; Fazlul H Sarkar
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

Review 3.  Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges.

Authors:  Imtiaz Khan; Aliya Ibrar; Sumera Zaib
Journal:  Top Curr Chem (Cham)       Date:  2021-01-05

Review 4.  Multitargeting by curcumin as revealed by molecular interaction studies.

Authors:  Subash C Gupta; Sahdeo Prasad; Ji Hye Kim; Sridevi Patchva; Lauren J Webb; Indira K Priyadarsini; Bharat B Aggarwal
Journal:  Nat Prod Rep       Date:  2011-10-06       Impact factor: 13.423

Review 5.  Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.

Authors:  Rama I Mahran; Magda M Hagras; Duxin Sun; Dean E Brenner
Journal:  AAPS J       Date:  2016-10-25       Impact factor: 4.009

6.  Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC.

Authors:  Jun Ma; Lynetta Phillips; Ying Wang; Tiane Dai; Janine LaPage; Rama Natarajan; Sharon G Adler
Journal:  BMC Complement Altern Med       Date:  2010-11-12       Impact factor: 3.659

7.  (E)-4-Chloro-N-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methyl-ene]aniline.

Authors:  Yu-Guo Zhuang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-09-09

8.  Early anti-oxidative and anti-proliferative curcumin effects on neuroglioma cells suggest therapeutic targets.

Authors:  Heena D Panchal; Karen Vranizan; Chun Y Lee; Jacqueline Ho; John Ngai; Paola S Timiras
Journal:  Neurochem Res       Date:  2008-02-26       Impact factor: 3.996

9.  Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects.

Authors:  Fahad Ibrahim Al-Jenoobi; Areej A Al-Thukair; Mohd Aftab Alam; Fawkeya A Abbas; Abdullah M Al-Mohizea; Khalid M Alkharfy; Saleh A Al-Suwayeh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-02-09       Impact factor: 2.441

10.  Synthesis and evaluation of electron-rich curcumin analogues.

Authors:  Michael W Amolins; Laura B Peterson; Brian S J Blagg
Journal:  Bioorg Med Chem       Date:  2008-10-29       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.